Molecular Biology and Human Genetics

Permanent URI for this community

https://scholar.sun.ac.za/handle/10019.1/140

Browse

Browsing Molecular Biology and Human Genetics by browse.metadata.type "Editorial"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Bedaquiline microheteroresistance after cessation of tuberculosis treatment
    (Massachusetts Medical Society, 2019-05-30) De Vos, Margaretha; Wiggins, Kristin B.; Derendinger, Brigitta; Reuter, Anja; Dolby, Tania; Burns, Scott; Schito, Marco; Engelthaler, David M.; Metcalfe, John; Theron, Grant; Van Rie, Annelies; Posey, James; Warren, Rob; Cox, Helen
    ENGLISH ABSTRACT: Bedaquiline improves survival among persons with multidrug-resistant tuberculosis (MDR-TB).1 We report the case of a 65-year-old South African man who was negative for human immunodeficiency virus and in whom MDR-TB was diagnosed in 2013 (resistant to rifampin and isoniazid; phenotypically susceptible to a fluoroquinolone and amikacin). A baseline radiograph showed changes consistent with bilateral tuberculosis with left apex cavitation. He started standardized treatment that included moxifloxacin, pyrazinamide, kanamycin, ethionamide, isoniazid, and terizidone. After initial sputum culture conversion (at month 3) and clinical improvement, the patient again became culture-positive, and bilateral cavitation developed. After detection of phenotypic resistance to fluoroquinolones (at month 6), his treatment was revised (at month 8) to include high-dose isoniazid, ethambutol, pyrazinamide, terizidone, linezolid, paraaminosalicylic acid, and kanamycin (Figure 1 and the Supplementary Appendix, available with the full text of this letter at NEJM.org). Bedaquiline was added 22 days later and was administered for 6 months.2 The patient remained culture-positive (treatment failure), and treatment was stopped 15 months after revision of the regimen. The patient died 7 months later.
  • Thumbnail Image
    Item
    Editorial : Bovine Tuberculosis—International perspectives on epidemiology and management
    (Frontiers Media, 2019-06-25) Byrne, Andrew W.; Allen, Adrian R.; O'Brien, Daniel J.; Miller, Michele A.
    Introduction: Bovine tuberculosis (bTB) remains a prominent zoonotic pathogen on the world stage, with significant impacts on animal and human health, and economic well-being. Eradication is hampered by a complex epidemiology, which in many countries involves wildlife hosts. Indeed, despite advances in understanding gleaned from national programs of bTB eradication, much of our understanding of transmission mechanisms, diagnostics, control, and multi-host infection systems remains opaque. In this collection of Frontiers in Veterinary Science, as editors, we felt these limitations could best be addressed by adopting an international perspective. Localism understandably focuses on the fine details of problems at hand, but can perhaps overlook issues that only become apparent when compared to the experiences of others. Below we summarize the papers published in this truly international collection, and highlight some themes. We trust readers will find these articles as stimulating to read as they were to edit.